about
Contrasting disease patterns in seropositive and seronegative neuromyelitis optica: A multicentre study of 175 patientsA new Purkinje cell antibody (anti-Ca) associated with subacute cerebellar ataxia: immunological characterizationThe history of neuromyelitis optica'Medusa head ataxia': the expanding spectrum of Purkinje cell antibodies in autoimmune cerebellar ataxia. Part 3: Anti-Yo/CDR2, anti-Nb/AP3B2, PCA-2, anti-Tr/DNER, other antibodies, diagnostic pitfalls, summary and outlookUpdate on biomarkers in neuromyelitis opticaEvaluation of a multiparametric immunofluorescence assay for standardization of neuromyelitis optica serologyDifferential diagnosis of suspected multiple sclerosis: a consensus approachMOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 2: Epidemiology, clinical presentation, radiological and laboratory features, treatment responses, and long-term outcomeDiagnostic biomarkers in multiple sclerosis.Neuromyelitis optica: clinical features, immunopathogenesis and treatment.Neuromyelitis optica in Brazil: a study on clinical and prognostic factors.Patterns of antibody binding to aquaporin-4 isoforms in neuromyelitis optica.Optical coherence tomography helps differentiate neuromyelitis optica and MS optic neuropathies.An immunoassay that distinguishes real neuromyelitis optica signals from a labeling detected in patients receiving natalizumabAquaporin-4 antibody testing: direct comparison of M1-AQP4-DNA-transfected cells with leaky scanning versus M23-AQP4-DNA-transfected cells as antigenic substrate.Aquaporin-4 autoantibodies in neuromyelitis optica spectrum disorders: comparison between tissue-based and cell-based indirect immunofluorescence assays.Cerebrospinal fluid antibodies to aquaporin-4 in neuromyelitis optica and related disorders: frequency, origin, and diagnostic relevanceScreening for MOG-IgG and 27 other anti-glial and anti-neuronal autoantibodies in 'pattern II multiple sclerosis' and brain biopsy findings in a MOG-IgG-positive case.Comparison between the cranial magnetic resonance imaging features of neuromyelitis optica spectrum disorder versus multiple sclerosis in Taiwanese patientsCD19 as a molecular target in CNS autoimmunity.Antibodies to the inositol 1,4,5-trisphosphate receptor type 1 (ITPR1) in cerebellar ataxia.Update on the diagnosis and treatment of neuromyelitis optica: recommendations of the Neuromyelitis Optica Study Group (NEMOS).Central Nervous System Idiopathic Inflammatory Demyelinating Disorders in South Americans: A Descriptive, Multicenter, Cross-Sectional StudySerologic diagnosis of NMO: a multicenter comparison of aquaporin-4-IgG assays.The role of anti-aquaporin 4 antibody in the conversion of acute brainstem syndrome to neuromyelitis optica.Anti-AQP(4) antibody in idiopathic acute transverse myelitis with recurrent clinical course: frequency of positivity and influence in prognosis.Antibody to aquaporin-4 in the long-term course of neuromyelitis optica.Pelvic pain as an unusual first presentation of a demyelinating disease.Neuromyelitis optica: an often forgotten cause of intractable nausea and vomiting.Neuromyelitis optica-IgG testing in an Indian cohort with neuromyelitis optica and related demyelinating disorders: Our experience.MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 1: Frequency, syndrome specificity, influence of disease activity, long-term course, association with AQP4-IgG, and origin.Evaluation of aquaporin-4 antibody assays.The Presence of Autoantibodies Against Vascular and Nervous Tissue in Sera From Patients with Neuro-Behçet's Disease.Clinical, paraclinical and serological findings in Susac syndrome: an international multicenter study.Neuromyelitis optica (NMO)--an autoimmune disease of the central nervous system (CNS).Aquaporins and neurodegenerative diseases.Anti-aquaporin-4 antibodies in Devic's neuromyelitis optica: therapeutic implications.The limited demyelinating diseases: the voyage of optic neuritis and transverse myelitis to multiple sclerosis and neuromyelitis.The differential diagnosis of longitudinally extensive transverse myelitis.Neuromyelitis optica spectrum disorders in patients with myasthenia gravis: ten new aquaporin-4 antibody positive cases and a review of the literature.
P2860
Q21093230-F7097A82-0E07-49F1-A1F1-2EA1911CDCCEQ21245233-B7045AF0-5F45-4074-966C-1339EC96627EQ21245248-CC2AAB57-1B5E-4CDC-8B0A-58CB1D14DB7BQ26786089-E34074D7-05BE-4CF3-9998-321C403234ABQ26799789-B5805C73-486F-43AA-89A3-8D5724DE60E1Q28728565-9079E256-ECF3-4D57-BC24-753C79BBB528Q29039412-516BEC4A-D439-4BF5-BE77-20B1632C1236Q30371412-04A734D6-7881-40A4-AFC6-04BB0357501FQ30598338-B259A5B5-6CFA-4CBF-BC14-ED6797A2EAC0Q30785267-F41F494C-CBA0-4390-9E4C-08EAB635A2FCQ33419781-843608C3-F48C-409B-B0B0-4E8A62D82084Q33576962-3F21EB30-FE3F-483F-8C7B-FC2EAB500FA0Q33745618-69F07317-6B5D-4506-916A-CEA81FE0CAA5Q33895664-1509BBD5-2B36-494B-B064-08AB7F640A4BQ34026880-5D5CBD12-8D47-4A8E-A20B-6DB2D5C594B0Q34138884-85324F56-C717-4E64-91B0-10A28B0A14BBQ34154277-A8157199-3E01-4035-8B5E-5447DAAFDDE9Q34513731-8E2E457D-5B7B-4D68-9FEF-99F3613A2D50Q34687502-BF97B0CB-7F07-4D0B-AADD-C84645E91B7CQ34976749-0593F602-F7F1-49BC-BEEF-3842C8B7191EQ34990974-B63229AF-8FF6-4805-94B2-7C9D62D38425Q35052199-B164B98A-4927-4118-B82A-6FA67EBEAB5DQ35722940-16E084E9-F16E-4FA2-8867-EE36131C3691Q35776490-53780E60-3B11-4E08-B722-51F7CB1B4696Q36171516-7B003DA9-41D1-4E8E-8DA4-B0BD80F58482Q36183920-DE7C8326-0755-4C4D-A324-3014B9811CB3Q36961015-7986EF10-B879-472B-BB87-CE5159B67275Q36979551-4E2B5B86-4B3A-4676-A1B1-96EC11CA0697Q37057962-FABDCB85-2027-471B-B19C-FC51DF60F81DQ37210403-A8301F06-780C-45EC-81AF-079D0FF1982BQ37374434-91129534-3D76-4838-A423-DDBB6EBE4470Q37404328-0747E17E-796A-405F-AFB1-8F905C03B623Q37703882-4553F814-B2BE-4E71-BEBC-3F572AAB6349Q37717025-39D4B355-71EB-4C4D-8D94-77A69FADF5A7Q37794273-3D7128DE-217C-4488-8A90-BBD0E65B0FD6Q37814121-02D4EC1F-CF7D-42C3-84FC-986F0D3DCBF2Q37823233-B5080AF6-6D89-486F-BD2A-6B9C91B32E85Q37849770-BEBA60A6-8252-4715-B0D4-8784D500DCF2Q37888959-6FBE2128-E6CD-4BCB-8E90-36AB9DF36873Q37970036-8C8903B5-2225-4C07-BADF-3C45752921A2
P2860
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh-hant
name
NMO-IgG in the diagnosis of neuromyelitis optica.
@en
NMO-IgG in the diagnosis of neuromyelitis optica.
@nl
type
label
NMO-IgG in the diagnosis of neuromyelitis optica.
@en
NMO-IgG in the diagnosis of neuromyelitis optica.
@nl
prefLabel
NMO-IgG in the diagnosis of neuromyelitis optica.
@en
NMO-IgG in the diagnosis of neuromyelitis optica.
@nl
P2093
P1433
P1476
NMO-IgG in the diagnosis of neuromyelitis optica.
@en
P2093
Bergamaschi R
Franciotta D
Hohlfeld R
Littleton E
P304
P356
10.1212/01.WNL.0000256822.01222.BD
P407
P577
2007-02-07T00:00:00Z